Navellier & Associates Inc Quest Diagnostics Inc Transaction History

Navellier & Associates Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$120.62 - $141.12 $109,040 - $127,572	904 Added 32.8%	3,660 $504,000
Q3 2023 Nov 09, 2023	BUY	$121.86 - $144.92 $26,443 - $31,447	217 Added 8.55%	2,756 $335,000
Q2 2023 Aug 07, 2023	BUY	$130.56 - $146.84 $53,790 - $60,498	412 Added 19.37%	2,539 $356,000
Q1 2023 May 12, 2023	BUY	$131.53 - $155.76 $15,257 - $18,068	116 Added 5.77%	2,127 $300,000
Q4 2022 Feb 02, 2023	SELL	$123.31 - $157.26 $1,109 - $1,415	-9 Reduced 0.45%	2,011 $314,000
Q3 2022 Nov 09, 2022	SELL	$121.77 - $141.1 $4,140 - $4,797	-34 Reduced 1.66%	2,020 $248,000
Q1 2022 Apr 29, 2022	BUY	$129.09 - $164.35 $6,841 - $8,710	53 Added 2.65%	2,054 $281,000
Q4 2021 Feb 14, 2022	SELL	$140.36 - $173.01 $982 - $1,211	-7 Reduced 0.35%	2,001 $346,000
Q2 2021 Aug 09, 2021	SELL	$126.66 - $141.48 $1,393 - $1,556	-11 Reduced 0.54%	2,008 $265,000
Q1 2021 May 12, 2021	SELL	$114.63 - $133.34 $1,375 - $1,600	-12 Reduced 0.59%	2,019 $259,000
Q4 2020 Feb 05, 2021	BUY	$112.7 - $128.05 $228,893 - $260,069	2,031 New	2,031 $242,000

925

95.1M

379K

354K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.